MedTrace Logo

Artemisia and Green Tea Extracts for Gastric Mucosal Health

NCT06628804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-13

No results posted yet for this study

Summary

This clinical trial aims to determine whether Artemisia and green tea extracts promote gastric mucosal health in adults with functional dyspepsia and to assess its safety.

The main questions are:

* Does Artemisia and green tea extracts promote gastric mucosal health in participants?
* What side effects occur when participants take Artemisia and green tea extracts?

Conditions

  • Functional Dysphonia

Interventions

DIETARY_SUPPLEMENT

Artemisia and green tea extracts

Artemisia and green tea extracts 700 mg/day for 8 weeks

DIETARY_SUPPLEMENT

Placebo

Placebo 700 mg/day for 8 weeks

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Sang Yeoup Lee, MD,PhD · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-12-30
Completion
2025-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06628804 on ClinicalTrials.gov